Dynamic Stability Exercise Program for Thumb Basal Joint Osteoarthritis

Phase-Based Progress Estimates
Thumb Basal Joint Osteoarthritis+2 More
Dynamic Stability Exercise Program - Other
All Sexes
What conditions do you have?

Study Summary

This trial will help determine if a novel exercise regimen reduces radiographic thumb CMC joint misalignment among persons with thumb carpometacarpal osteoarthritis.

Eligible Conditions
  • Thumb Basal Joint Osteoarthritis
  • Thumb Carpometacarpal Osteoarthritis

Treatment Effectiveness

Effectiveness Progress

1 of 3

Study Objectives

2 Primary · 0 Secondary · Reporting Duration: 12 weeks post intervention

12 weeks post intervention
Subluxation of thumb carpometacarpal joint as per Fluoroscopy.
6 weeks post intervention
Sonography, Speech

Trial Safety

Safety Progress

2 of 3
This is further along than 68% of similar trials

Trial Design

1 Treatment Group

Dynamic Stability Exercise Program
1 of 1
Experimental Treatment

49 Total Participants · 1 Treatment Group

Primary Treatment: Dynamic Stability Exercise Program · No Placebo Group · Phase 2

Dynamic Stability Exercise Program
Experimental Group · 1 Intervention: Dynamic Stability Exercise Program · Intervention Types: Other

Trial Logistics

Trial Timeline

Approximate Timeline
Screening: ~3 weeks
Treatment: Varies
Reporting: 12 weeks post intervention

Who is running the clinical trial?

University of MinnesotaLead Sponsor
1,239 Previous Clinical Trials
1,460,629 Total Patients Enrolled
Corey McGeePrincipal InvestigatorUMN

Eligibility Criteria

Age 18+ · All Participants · 1 Total Inclusion Criteria

Mark “yes” if the following statements are true for you:

About The Reviewer

Michael Gill preview

Michael Gill - B. Sc.

First Published: October 28th, 2021

Last Reviewed: October 30th, 2022

Michael Gill holds a Bachelors of Science in Integrated Science and Mathematics from McMaster University. During his degree he devoted considerable time modeling the pharmacodynamics of promising drug candidates. Since then, he has leveraged this knowledge of the investigational new drug ecosystem to help his father navigate clinical trials for multiple myeloma, an experience which prompted him to co-found Power Life Sciences: a company that helps patients access randomized controlled trials.

Who else is applying?

What state do they live in?
How old are they?
What site did they apply to?
University of Minnesota100.0%
What portion of applicants met pre-screening criteria?
Met criteria100.0%